A policy group of the American College of Medical Genetics and Genomics recently recommended guidelines for informing patients about one or more secondary conditions discovered when genome or exome sequencing is done for a primary finding. The recommendation is that patients should be told about the risk of the secondary condition if a treatment exists to remedy it, but not if there is none.  Apparently, this group believes that incurable diseases are untreatable, which is not the case, if only for quality of life issues.  Lawsuits probably will cure the ACMCG of keeping secrets from patients.   MORE